Provider QP21-20 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Baclofen Read More
Provider QP18-20 Pharmacy Benefit Exclusion for Calcipotriene-Betamethasone Dipropionate Suspension 0.005-0.064% (authorized generic (AG) of Taclonex suspension) Read More
Provider P12-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements Read More
Provider P10-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates – Effective April 6, 2020 Read More
Provider P13-20 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers- eviCore Healthcare Utilization Management (UM) Program Read More
Provider P11-20 Updated Bulletin: Commercial Inpatient Admission Notification Process Changes Read More
